Anti-HIV antiviral activity of stavudine in a thymidine kinase-deficient cellular line

Antiviral Therapy

Volumn 3, Issue 3, 1998, Pages 191-194

  Turriziani, Ombretta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEOTIDE; RNA DIRECTED DNA POLYMERASE; STAVUDINE; THYMIDINE KINASE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PHOSPHORYLATION; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CELL LINE; HUMANS; PHOSPHORYLATION; STAVUDINE; THYMIDINE KINASE;

EID: 0031769735     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hammer SM, Katzenstein DA, Hughs MD, Gundacker MD, Schooley RT, Haubrich RH, Henry WK, Lederman MM, Phair JP, Hirsch MS & Merigan TC for the AIDS Clinical Trial Group Study 175 Study Team. A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500/μl. New England Journal of Medicine 1996; 335:1081-1090.
2. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combination of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1995; 348:283-291.
3. Gao WY, Shirasaka T, Johns DG, Broder S & Mitsuya H. Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells. Journal of Clinical Investigation 1993; 91:2326-2333.
4. Caliendo AM & Hirsch MS. Combination therapy for infection due to human immunodeficiency virus type 1. Clinical Infectious Diseases 1994; 18:516-524.
5. Perno CF, Yarchoan R, Balzarini J, Bergamini A, Milanese G, Pawels R, De Clercq E, Rocchi G & Calio R. Different pattern of activity of inhibitors of the human immunodeficiency virus in lymphocytes and monocytes/macrophages. Antiviral Research 1992; 17:289-304.
6. Merril DP, Moonis M, Chou TC & Hirsch MS. Lamivudine or stavudine in two-and three-drug combination against human immunodeficiency virus type 1 replication in vitro. Journal of Infectious Diseases 1996; 173:355-364.
7. Saag MS, Holodniy M, Kuritzkes DR, O'Brie WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD & Volberding PA. HIV viral load markers in clinical practice. Nature Medicine 1996; 2:625-629.
8. Browne MJ, Mayer KH, Chafee SBD, Dudley MN, Posner MR, Steinberg SM, Graham KK, Geletko SM, Zinner SH, Demamn SL, Dunkle LM, Kaul S, McLaren C, Skowron G, Kouttab NM, Kennedy TA, Weitberg AB, Curt GA. 2',3'-didehydro-3'deoxy-thymidine (d4T) in patients with AIDS or AlDS-related complex: a phase 1 trial. Journal of Infectious Diseases 1993; 167:21-29.
9. Murray HM, Squires KE, Weiss W, Sledz S, Sacks HS, Hassett J, Cross A, Anderson RE & Dunkle LM. Stavudine in patients with AIDS and AIDS-related complex: AIDS clinical trial group 089. Journal of Infectious Diseases 1995; 17:5123-5130.
10. Balzarini J, Herdewijn P & De Clercq E. Differential patterns of intracellular metabolism of 2',3'-didehydro-3'-deoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. Journal of Biological Chemistry 1989; 264:6127-6133.
11. Ho H & Hitchcock MJM. Cellular pharmacology of 2'-3'-dideoxy-2',3'-didehydrothymidine, a nucleoside analog active against human immunodeficiency virus. Antimicrobial Agents and Chemotherapy 1989; 33:844-849.
12. Zhu Z, Ho H, Hitchcock KL & Sommadossi J. Cellular pharmacology of 2',3'-didehydro-3'deoxy-thymidine (d4T) in human peripheral blood mononuclear cells. Biochemical Pharmacology 1990; 39:R15-R19.
13. Sommadossi J. Nucleoside analogs: similarities and differences. Clinical Infectious Disease 1993; 16:S7-S15.
14. Furman PA, Fyfe JA, St Clair MH, Weinhol K, Rideout JL, Freeman JA, Lehrman SN, Bolognesi DP, Broder S, Miysuya H & Barry DW. Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. Proceedings of the National Academy Sciences, USA 1986; 83:8333-8337.